+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Stem Cells Market Research Report by Therapeutic Application, by Cell Source, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4857951
  • Report
  • July 2021
  • Region: Global
  • 181 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Stem Cells Market will Grow to USD 378.52 Million by 2026, at a CAGR of 16.72%

FEATURED COMPANIES

  • AlloSource, Inc.
  • BioRestorative Therapies
  • Gamida-Cell Ltd.
  • MEDIPOST Co., Ltd.
  • Orthofix
  • RTI Surgical
  • MORE
The Global Stem Cells Market size was estimated at USD 149.67 Million in 2020 and expected to reach USD 174.20 Million in 2021, at a Compound Annual Growth Rate (CAGR) 16.72% to reach USD 378.52 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Stem Cells to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Therapeutic Application, the Stem Cells Market was examined across Cardiovascular Diseases, Gastrointestinal Diseases, Musculoskeletal Disorders, Surgeries, and Wounds and Injuries.
  • Based on Type, the Stem Cells Market was examined across Allogeneic Stem Cell Therapy and Autologous. The Allogeneic Stem Cell Therapy was further studied across Acute Graft-Versus-Host Disease, Musculoskeletal Disorders, Surgeries, and Wounds and Injuries. The Autologous was further studied across Cardiovascular Diseases, Gastrointestinal Diseases, and Wounds and Injuries.
  • Based on Cell Source, the Stem Cells Market was examined across Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, and Cord Blood/Embryonic Stem Cells.
  • Based on Geography, the Stem Cells Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas was further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific was further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa was further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Stem Cells Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Stem Cells Market, including AlloSource, Inc., Anterogen Co., Ltd., Athersys, Inc, BioRestorative Therapies, BrainStorm, Cellular Biomedicine Group, Inc., CORESTEM Inc., Gamida-Cell Ltd., Holostem Terapie Avanzate Srl, Hope Biosciences, Kangstem Biotech, MEDIPOST Co., Ltd., NuVasive, Inc., Nuvasive, Inc., Orthofix, Pharmicell Co.,Ltd., Pluristem Therapeutics, RTI Surgical, RTI Surgical, Inc., Smith & Nephew PLC, Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Company Limited, and ViaCyte.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Stem Cells Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Stem Cells Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Stem Cells Market?
4. What is the competitive strategic window for opportunities in the Global Stem Cells Market?
5. What are the technology trends and regulatory frameworks in the Global Stem Cells Market?
6. What is the market share of the leading vendors in the Global Stem Cells Market?
7. What modes and strategic moves are considered suitable for entering the Global Stem Cells Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AlloSource, Inc.
  • BioRestorative Therapies
  • Gamida-Cell Ltd.
  • MEDIPOST Co., Ltd.
  • Orthofix
  • RTI Surgical
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Therapeutic Application Outlook
3.4. Type Outlook
3.5. Cell Source Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness related to the potential stem cell therapy for effective disease management
5.1.1.2. Introduction of advanced Genome-based cell analysis techniques
5.1.1.3. Increasing investment for the development of stem cell therapies
5.1.1.4. Infrastructural development related to stem cell banking and processing
5.1.2. Restraints
5.1.2.1. Loosely defined regulatory guidelines for commercialization and development
5.1.2.2. Associated social-ethical issues
5.1.3. Opportunities
5.1.3.1. Supportive regulations across developing countries
5.1.3.2. Emergence of IPSCs as effective alternative to ESCs
5.1.4. Challenges
5.1.4.1. Technical limitations
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Stem Cells Market, by Therapeutic Application
6.1. Introduction
6.2. Cardiovascular Diseases
6.3. Gastrointestinal Diseases
6.4. Musculoskeletal Disorders
6.5. Surgeries
6.6. Wounds and Injuries

7. Stem Cells Market, by Type
7.1. Introduction
7.2. Allogeneic Stem Cell Therapy
7.2.1. Acute Graft-Versus-Host Disease
7.2.2. Musculoskeletal Disorders
7.2.3. Surgeries
7.2.4. Wounds and Injuries
7.3. Autologous
7.3.1. Cardiovascular Diseases
7.3.2. Gastrointestinal Diseases
7.3.3. Wounds and Injuries

8. Stem Cells Market, by Cell Source
8.1. Introduction
8.2. Adipose Tissue-Derived Mesenchymal Stem Cells
8.3. Bone Marrow-Derived Mesenchymal Stem Cells
8.4. Cord Blood/Embryonic Stem Cells

9. Americas Stem Cells Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Stem Cells Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Stem Cells Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AlloSource, Inc.
13.2. Anterogen Co., Ltd.
13.3. Athersys, Inc
13.4. BioRestorative Therapies
13.5. BrainStorm
13.6. Cellular Biomedicine Group, Inc.
13.7. CORESTEM Inc.
13.8. Gamida-Cell Ltd.
13.9. Holostem Terapie Avanzate Srl
13.10. Hope Biosciences
13.11. Kangstem Biotech
13.12. MEDIPOST Co., Ltd.
13.13. NuVasive, Inc.
13.14. Nuvasive, Inc.
13.15. Orthofix
13.16. Pharmicell Co.,Ltd.
13.17. Pluristem Therapeutics
13.18. RTI Surgical
13.19. RTI Surgical, Inc.
13.20. Smith & Nephew PLC
13.21. Stempeutics Research Pvt. Ltd.
13.22. Takeda Pharmaceutical Company Limited
13.23. ViaCyte

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL STEM CELLS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2020 (USD MILLION)
FIGURE 3. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 4. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2020 (USD MILLION)
FIGURE 5. GLOBAL STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL STEM CELLS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL STEM CELLS MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL STEM CELLS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2020 VS 2026 (%)
FIGURE 10. GLOBAL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2026
FIGURE 12. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL STEM CELLS MARKET SIZE, BY SURGERIES, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL STEM CELLS MARKET SIZE, BY SURGERIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 23. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2026
FIGURE 25. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL STEM CELLS MARKET SIZE, BY ACUTE GRAFT-VERSUS-HOST DISEASE, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL STEM CELLS MARKET SIZE, BY ACUTE GRAFT-VERSUS-HOST DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL STEM CELLS MARKET SIZE, BY SURGERIES, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL STEM CELLS MARKET SIZE, BY SURGERIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, 2018-2026 (USD MILLION)
FIGURE 34. GLOBAL STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 35. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, 2018-2026 (USD MILLION)
FIGURE 36. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 37. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2020 VS 2026 (%)
FIGURE 44. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2020 VS 2026 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2026
FIGURE 46. GLOBAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 48. GLOBAL STEM CELLS MARKET SIZE, BY BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL STEM CELLS MARKET SIZE, BY BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 50. GLOBAL STEM CELLS MARKET SIZE, BY CORD BLOOD/EMBRYONIC STEM CELLS, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL STEM CELLS MARKET SIZE, BY CORD BLOOD/EMBRYONIC STEM CELLS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 52. AMERICAS STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 53. AMERICAS STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 55. ARGENTINA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 56. BRAZIL STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 57. CANADA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 58. MEXICO STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 60. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 61. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 63. AUSTRALIA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 64. CHINA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 65. INDIA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 66. INDONESIA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 67. JAPAN STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 68. MALAYSIA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 69. PHILIPPINES STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 70. SINGAPORE STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 71. SOUTH KOREA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 72. THAILAND STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
FIGURE 74. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
FIGURE 75. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2026
FIGURE 76. FRANCE STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 77. GERMANY STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 78. ITALY STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 79. NETHERLANDS STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 80. QATAR STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 81. RUSSIA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 82. SAUDI ARABIA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 83. SOUTH AFRICA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 84. SPAIN STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 85. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 86. UNITED KINGDOM STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 87. GLOBAL STEM CELLS MARKET: FPNV POSITIONING MATRIX
FIGURE 88. GLOBAL STEM CELLS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 89. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL STEM CELLS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL STEM CELLS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 5. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL STEM CELLS MARKET SIZE, BY SURGERIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENEIC STEM CELL THERAPY, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL STEM CELLS MARKET SIZE, BY ACUTE GRAFT-VERSUS-HOST DISEASE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL STEM CELLS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL STEM CELLS MARKET SIZE, BY SURGERIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL STEM CELLS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL STEM CELLS MARKET SIZE, BY WOUNDS AND INJURIES, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL STEM CELLS MARKET SIZE, BY ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL STEM CELLS MARKET SIZE, BY BONE MARROW-DERIVED MESENCHYMAL STEM CELLS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL STEM CELLS MARKET SIZE, BY CORD BLOOD/EMBRYONIC STEM CELLS, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 24. AMERICAS STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 25. AMERICAS STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 26. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 27. AMERICAS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 28. ARGENTINA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 29. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 30. ARGENTINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 31. BRAZIL STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 32. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 33. BRAZIL STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 34. CANADA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 35. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 36. CANADA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 37. MEXICO STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 38. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 39. MEXICO STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 40. UNITED STATES STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 41. UNITED STATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 43. UNITED STATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 44. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 45. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 46. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 47. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 48. AUSTRALIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 49. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 50. AUSTRALIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 51. CHINA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 52. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 53. CHINA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 54. INDIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 55. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 56. INDIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 57. INDONESIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 58. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 59. INDONESIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 60. JAPAN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 61. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 62. JAPAN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 63. MALAYSIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 64. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 65. MALAYSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 66. PHILIPPINES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 67. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 68. PHILIPPINES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 69. SINGAPORE STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 70. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 71. SINGAPORE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 72. SOUTH KOREA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 73. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 74. SOUTH KOREA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 75. THAILAND STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 76. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 77. THAILAND STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 82. FRANCE STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 83. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 84. FRANCE STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 85. GERMANY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 86. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 87. GERMANY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 88. ITALY STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 89. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 90. ITALY STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 91. NETHERLANDS STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 92. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 93. NETHERLANDS STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 94. QATAR STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 95. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 96. QATAR STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 97. RUSSIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 98. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 99. RUSSIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 100. SAUDI ARABIA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 101. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 102. SAUDI ARABIA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 103. SOUTH AFRICA STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 104. SOUTH AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 105. SOUTH AFRICA STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 106. SPAIN STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 107. SPAIN STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 108. SPAIN STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 112. UNITED KINGDOM STEM CELLS MARKET SIZE, BY THERAPEUTIC APPLICATION , 2018-2026 (USD MILLION)
TABLE 113. UNITED KINGDOM STEM CELLS MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 114. UNITED KINGDOM STEM CELLS MARKET SIZE, BY CELL SOURCE, 2018-2026 (USD MILLION)
TABLE 115. GLOBAL STEM CELLS MARKET: SCORES
TABLE 116. GLOBAL STEM CELLS MARKET: BUSINESS STRATEGY
TABLE 117. GLOBAL STEM CELLS MARKET: PRODUCT SATISFACTION
TABLE 118. GLOBAL STEM CELLS MARKET: RANKING
TABLE 119. GLOBAL STEM CELLS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 120. GLOBAL STEM CELLS MARKET: MERGER & ACQUISITION
TABLE 121. GLOBAL STEM CELLS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 122. GLOBAL STEM CELLS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 123. GLOBAL STEM CELLS MARKET: INVESTMENT & FUNDING
TABLE 124. GLOBAL STEM CELLS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 125. GLOBAL STEM CELLS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AlloSource, Inc.
  • Anterogen Co., Ltd.
  • Athersys, Inc
  • BioRestorative Therapies
  • BrainStorm
  • Cellular Biomedicine Group, Inc.
  • CORESTEM Inc.
  • Gamida-Cell Ltd.
  • Holostem Terapie Avanzate Srl
  • Hope Biosciences
  • Kangstem Biotech
  • MEDIPOST Co., Ltd.
  • NuVasive, Inc.
  • Nuvasive, Inc.
  • Orthofix
  • Pharmicell Co.,Ltd.
  • Pluristem Therapeutics
  • RTI Surgical
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Stempeutics Research Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited
  • ViaCyte
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll